Literature DB >> 24626868

Possible options for new pertussis vaccines.

Bruce D Meade1, Stanley A Plotkin, Camille Locht.   

Abstract

Increasing evidence that the currently available acellular pertussis vaccines are not providing optimal control of pertussis in the United States and many other countries has stimulated interest in improvements of the current vaccines and in the development of new vaccines. A better understanding of the limitations of the current vaccines and the basis for the pertussis resurgence is needed to design improved vaccines. This article outlines several alternate approaches and summarizes the challenges related to the development of new or modified vaccines.

Keywords:  Acellular Pertussis Vaccines; Resurgence

Mesh:

Substances:

Year:  2014        PMID: 24626868     DOI: 10.1093/infdis/jit531

Source DB:  PubMed          Journal:  J Infect Dis        ISSN: 0022-1899            Impact factor:   5.226


  19 in total

1.  Universal tetanus, diphtheria, acellular pertussis (Tdap) vaccination of adults: What Canadian health care providers know and need to know.

Authors:  D MacDougall; B A Halperin; D MacKinnon-Cameron; L Li; S A McNeil; J M Langley; S A Halperin
Journal:  Hum Vaccin Immunother       Date:  2015-06-19       Impact factor: 3.452

Review 2.  What Is Wrong with Pertussis Vaccine Immunity? The Problem of Waning Effectiveness of Pertussis Vaccines.

Authors:  Nicolas Burdin; Lori Kestenbaum Handy; Stanley A Plotkin
Journal:  Cold Spring Harb Perspect Biol       Date:  2017-12-01       Impact factor: 10.005

3.  Epidemiological and Economic Effects of Priming With the Whole-Cell Bordetella pertussis Vaccine.

Authors:  Haedi DeAngelis; Samuel V Scarpino; Meagan C Fitzpatrick; Alison P Galvani; Benjamin M Althouse
Journal:  JAMA Pediatr       Date:  2016-05-01       Impact factor: 16.193

4.  Use of a Toxin Neutralization Assay To Characterize the Serologic Response to Adenylate Cyclase Toxin after Infection with Bordetella pertussis.

Authors:  Joshua C Eby; Mary C Gray; Jason M Warfel; Tod J Merkel; Erik L Hewlett
Journal:  Clin Vaccine Immunol       Date:  2017-01-05

5.  Albumin, in the Presence of Calcium, Elicits a Massive Increase in Extracellular Bordetella Adenylate Cyclase Toxin.

Authors:  Laura A Gonyar; Mary C Gray; Gregory J Christianson; Borna Mehrad; Erik L Hewlett
Journal:  Infect Immun       Date:  2017-05-23       Impact factor: 3.441

Review 6.  No pain no gain? Adjuvant effects of alum and monophosphoryl lipid A in pertussis and HPV vaccines.

Authors:  Thomas C Mitchell; Carolyn R Casella
Journal:  Curr Opin Immunol       Date:  2017-07-17       Impact factor: 7.486

7.  Alternatives to HIST for acellular pertussis vaccines: progress and challenges in replacement.

Authors:  J Arciniega; L Wagner; R Prymula; P Sebo; R Isbrucker; B Descampe; J M Chapsal; A Costanzo; C Hendriksen; M Hoonaker; S Nelson; K Lidster; W Casey; D Allen
Journal:  Pharmeur Bio Sci Notes       Date:  2016

Review 8.  Pertussis: Microbiology, Disease, Treatment, and Prevention.

Authors:  Paul E Kilgore; Abdulbaset M Salim; Marcus J Zervos; Heinz-Josef Schmitt
Journal:  Clin Microbiol Rev       Date:  2016-07       Impact factor: 26.132

9.  Comparison of Three Whole-Cell Pertussis Vaccines in the Baboon Model of Pertussis.

Authors:  Jason M Warfel; Lindsey I Zimmerman; Tod J Merkel
Journal:  Clin Vaccine Immunol       Date:  2015-11-11

Review 10.  Review of the neutrophil response to Bordetella pertussis infection.

Authors:  Joshua C Eby; Casandra L Hoffman; Laura A Gonyar; Erik L Hewlett
Journal:  Pathog Dis       Date:  2015-10-02       Impact factor: 3.951

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.